Literature DB >> 2991343

Resistance of human tumor cells in vitro to oxidative cytolysis.

J O'Donnell-Tormey, C J DeBoer, C F Nathan.   

Abstract

Nine human cell types, six of them malignant, displayed a marked resistance to lysis by hydrogen peroxide (LD50, 2-20 mM). Of the reactive oxygen intermediates generated extracellularly, only H2O2 lysed all the cell types. OH was lytic to one of four, OI- to one of one, and O-2 to none of four cell types tested. Resistance to oxidative lysis did not correlate with specific activity of catalase, glutathione (GSH) peroxidase, other peroxidases, or glutathione disulfide reductase, or with specific content of GSH. Resistance to H2O2 seemed to occur via mechanisms distinct from those responsible for cellular consumption of H2O2. Consumption was inhibitable by azide and was probably due to catalase in each cell type. In contrast, resistance to oxidative lysis occurred via distinct routes in different cells. One cell type used the GSH redox cycle as the primary defense against H2O2, like murine tumors previously studied. Other cells seemed to utilize catalase as the major defense against H2O2. Nonetheless, with both catalase and the GSH redox cycle inhibited, all the human cells tested exhibited an inherent resistance to oxidative lysis, that is, resistance independent of detectable degradation of H2O2.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2991343      PMCID: PMC423713          DOI: 10.1172/JCI111981

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  49 in total

1.  The assay of catalases and peroxidases.

Authors:  A C MAEHLY; B CHANCE
Journal:  Methods Biochem Anal       Date:  1954

Review 2.  Role of superoxide dismutase in cancer: a review.

Authors:  L W Oberley; G R Buettner
Journal:  Cancer Res       Date:  1979-04       Impact factor: 12.701

3.  The interaction of hydroxyl radicals with dimethylsulfoxide produces formaldehyde.

Authors:  S M Klein; G Cohen; A I Cederbaum
Journal:  FEBS Lett       Date:  1980-07-28       Impact factor: 4.124

4.  Use of an oxidase electrode to determine factors affecting the in vitro production of hydrogen peroxide by Ehrlich cells and 1-chloro-2, 4-dinitrobenzene.

Authors:  C B Schroy; J E Biaglow
Journal:  Biochem Pharmacol       Date:  1981-12-01       Impact factor: 5.858

5.  Peroxidative hemolysis of red blood cells from patients with abetalipoproteinemia (acanthocytosis).

Authors:  J T Dodge; G Cohen; H J Kayden; G B Phillips
Journal:  J Clin Invest       Date:  1967-03       Impact factor: 14.808

6.  Quantitative and temporal characterization of the extracellular H2O2 pool generated by human neutrophils.

Authors:  S T Test; S J Weiss
Journal:  J Biol Chem       Date:  1984-01-10       Impact factor: 5.157

7.  Human monocyte-mediated tumor cytotoxicity. I. Demonstration of an oxygen-dependent myeloperoxidase-independent mechanism.

Authors:  P Mavier; T S Edgington
Journal:  J Immunol       Date:  1984-04       Impact factor: 5.422

8.  Enzyme defense against reactive oxygen derivatives. II. Erythrocytes and tumor cells.

Authors:  A Bozzi; I Mavelli; A Finazzi; R Strom; A M Wolf; B Mondovi; G Rotilio
Journal:  Mol Cell Biochem       Date:  1976-01-31       Impact factor: 3.396

9.  Copper- and zinc-containing superoxide dismutase, manganese-containing superoxide dismutase, catalase, and glutathione peroxidase in normal and neoplastic human cell lines and normal human tissues.

Authors:  S L Marklund; N G Westman; E Lundgren; G Roos
Journal:  Cancer Res       Date:  1982-05       Impact factor: 12.701

10.  Differential sensitivity of tumor cells to externally generated hydrogen peroxide. Role of glutathione and related enzymes.

Authors:  A Bozzi; I Mavelli; B Mondovì; R Strom; G Rotilio
Journal:  Cancer Biochem Biophys       Date:  1979
View more
  14 in total

1.  Effects of tumor-necrosis-factor-activated neutrophils on tumor cell survival.

Authors:  H Shau
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

2.  A journey in science: promise, purpose, privilege.

Authors:  Carl Nathan
Journal:  Mol Med       Date:  2013-10-03       Impact factor: 6.354

3.  Oxidant-induced DNA damage of target cells.

Authors:  I Schraufstätter; P A Hyslop; J H Jackson; C G Cochrane
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

4.  Tumor progression to the metastatic state involves structural modifications in DNA markedly different from those associated with primary tumor formation.

Authors:  D C Malins; N L Polissar; S J Gunselman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

Review 5.  Beyond oxidative stress: an immunologist's guide to reactive oxygen species.

Authors:  Carl Nathan; Amy Cunningham-Bussel
Journal:  Nat Rev Immunol       Date:  2013-05       Impact factor: 53.106

6.  Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine.

Authors:  G Starkebaum; J M Harlan
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

7.  Involvement of Ras in survival responsiveness to nitric oxide toxicity in pheochromocytoma cells.

Authors:  Hyun Sik Jeong; Seong Won Kim; Kwang Jin Baek; Hee Sung Lee; Nyoun Soo Kwon; Young-Myeong Kim; Hye-Young Yun
Journal:  J Neurooncol       Date:  2002-11       Impact factor: 4.130

8.  A unified theory of carcinogenesis based on order-disorder transitions in DNA structure as studied in the human ovary and breast.

Authors:  D C Malins; N L Polissar; S Schaefer; Y Su; M Vinson
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

9.  Progression of human breast cancers to the metastatic state is linked to hydroxyl radical-induced DNA damage.

Authors:  D C Malins; N L Polissar; S J Gunselman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

10.  Inhibition of tumor growth by elimination of granulocytes.

Authors:  L A Pekarek; B A Starr; A Y Toledano; H Schreiber
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.